Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Enrollment is open for a phase 2 trial of a drug normally used to treat abnormal heart rhythms that showed promise in ALS mouse studies
Posted on Monday, July 15, 2013 - 05:00, By: Amy Madsen
Update (June 16, 2014): This trial is now closed to new participants.
Update (Jan. 28, 2014): This story has been updated with new contact information for the Boston and St. Louis centers.